6th Antifibrotic Drug Development Summit (AFDD)
Evvnt Promotion / evvnt
Archiv
09.11.2022 - 11.11.2022 Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, 01801 Woburn, USA
Time: 8:25 am to 5:00 pm
Kongressthemen
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre
Anfragen und Anmeldung:
https://go.evvnt.com/1241066-2?pid=4832
Frau Jessica Durston
Gesundheitsversorgung
Sprache
Englisch
Englisch
Kongressgebühr
USD 2199.00 - USD 5696.00
USD 2199.00 - USD 5696.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
